Back to 
CAPTRUST Financial Advisors
CAPTRUST Financial Advisors
SMMT
Showing 0 of 14 quarters
Position history for CAPTRUST Financial Advisors's holdings in Summit Therapeutics Inc.
No. CAPTRUST Financial Advisors exited its SMMT (Summit Therapeutics) position in Q3 2023. Its Q2 2023 13F listed 35,926 shares worth $90,174. CAPTRUST Financial Advisors first reported SMMT in Q2 2020 and held it in 12 quarterly 13F filings.
Current Value
—
Current Shares
—
Total Value Change
$0
Total Shares Change
0
No position history available for this security.